Abstract:Purpose: Artificial intelligence-based tools can be leveraged to improve detection and segmentation of brain metastases for stereotactic radiosurgery (SRS). VBrain by Vysioneer Inc. is a deep learning algorithm with recent FDA clearance to assist in brain tumor contouring. We aimed to assess the performance of this tool by various demographic and clinical characteristics among patients with brain metastases treated with SRS. Materials and methods: We randomly selected 100 patients with brain metastases who underwent initial SRS on the CyberKnife from 2017 to 2020 at a single institution. Cases with resection cavities were excluded from the analysis. Computed tomography (CT) and axial T1-weighted post-contrast magnetic resonance (MR) image data were extracted for each patient and uploaded to VBrain. A brain metastasis was considered "detected" when the VBrain- "predicted" contours overlapped with the corresponding physician contours ("ground-truth" contours). We evaluated performance of VBrain against ground-truth contours using the following metrics: lesion-wise Dice similarity coefficient (DSC), lesion-wise average Hausdorff distance (AVD), false positive count (FP), and lesion-wise sensitivity (%). Kruskal-Wallis tests were performed to assess the relationships between patient characteristics including sex, race, primary histology, age, and size and number of brain metastases, and performance metrics such as DSC, AVD, FP, and sensitivity. Results: We analyzed 100 patients with 435 intact brain metastases treated with SRS. Our cohort consisted of patients with a median number of 2 brain metastases (range: 1 to 52), median age of 69 (range: 19 to 91), and 50% male and 50% female patients. The primary site breakdown was 56% lung, 10% melanoma, 9% breast, 8% gynecological, 5% renal, 4% gastrointestinal, 2% sarcoma, and 6% other, while the race breakdown was 60% White, 18% Asian, 3% Black/African American, 2% Native Hawaiian or other Pacific Islander, and 17% other/unknown/not reported. The median tumor size was 0.112 c.c. (range: 0.010-26.475 c.c.). We found mean lesion-wise DSC to be 0.723, mean lesion-wise AVD to be 7.34% of lesion size (0.704 mm), mean FP count to be 0.72 tumors per case, and lesion-wise sensitivity to be 89.30% for all lesions. Moreover, mean sensitivity was found to be 99.07%, 97.59%, and 96.23% for lesions with diameter equal to and greater than 10 mm, 7.5 mm, and 5 mm, respectively. No other significant differences in performance metrics were observed across demographic or clinical characteristic groups. Conclusion: In this study, a commercial deep learning algorithm showed promising results in segmenting brain metastases, with 96.23% sensitivity for metastases with diameters of 5 mm or higher. As the software is an assistive AI, future work of VBrain integration into the clinical workflow can provide further clinical and research insights.

Development and Validation of a Fully Automatic Tissue Delineation Model for Brain Metastasis Using a Deep Neural Network.

Automated Clinical Target Volume Delineation Using Deep 3D Neural Networks in Radiation Therapy of Non-small Cell Lung Cancer

Automated Clinical Target Volume Delineation for Non-Small Cell Lung Cancer Patients Using Deep 3D Networks

Stratified assessment of an FDA-cleared deep learning algorithm for automated detection and contouring of metastatic brain tumors in stereotactic radiosurgery

Automatic Detection of Brain Metastases Using 3D Mask R-CNN for Stereotactic Radiosurgery

Deep-learning-driven Dose Prediction and Verification for Stereotactic Radiosurgical Treatment of Isolated Brain Metastases

AI-assisted Clinical Decision Making (CDM) for Dose Prescription in Radiosurgery of Brain Metastases Using Three-Path Three-Dimensional CNN

An Artificial Intelligence Framework for Automatic Segmentation and Volumetry of Vestibular Schwannomas from Contrast-Enhanced T1-weighted and High-Resolution T2-weighted MRI.

AI Evaluation of Imaging Factors in the Evolution of Stage-Treated Metastases Using Gamma Knife

Deep-learning magnetic resonance imaging-based automatic segmentation for organs-at-risk in the brain: Accuracy and impact on dose distribution

Automated Delineation of Head and Neck Organs at Risk Using Synthetic MRI-aided Mask Scoring Regional Convolutional Neural Network

Automated Segmentation of the Clinical Target Volume in the Planning CT for Breast Cancer Using Deep Neural Networks

Learning-Based Automatic Segmentation of Arteriovenous Malformations on Contrast CT Images in Brain Stereotactic Radiosurgery

Deep Learning-Aided Automatic Contouring of Clinical Target Volumes for Radiotherapy in Breast Cancer After Modified Radical Mastectomy

Deep Learning for Automated Contouring of Primary Tumor Volumes by MRI for Nasopharyngeal Carcinoma.

A web-based brain metastases segmentation and labeling platform for stereotactic radiosurgery

Automated segmentation of brain metastases with deep learning: A multi-center, randomized crossover, multi-reader evaluation study

Artificial Intelligence-Assisted Delineation for Postoperative Radiotherapy in Patients with Lung Cancer: A Prospective, Multi-Center, Cohort Study

An Artificial Intelligence-Based Full-Process Solution for Radiotherapy: A Proof of Concept Study on Rectal Cancer

Clinical evaluation of deep learning-based automatic clinical target volume segmentation: a single-institution multi-site tumor experience

Clinical target volume (CTV) automatic delineation using deep learning network for cervical cancer radiotherapy: A study with external validation